Abstract :

Exosomes are a subset of nano-sized (30–150 nm) extracellular vehicles (EVs) released by cells through the endosomal route, you know like they get made inside and then pushed out.

Objective: The primary objective of this scientific review is to give a broad and current appraisal of the intricate biological layout of exosomes, plus modern isolation technologies (for instance microfluidics and spectroscopy), and finally their clinical meaning for cancer detection and treatment.

Methods: This article is arranged following systematic review logic based on credible scientific sources from the last decade 2015–2025. Data collection involved international databases, including PubMed, Scopus and Web of Science. The analysis looks at how exosome biogenesis connects with drug delivery systems (DDS), and how that whole interplay affects the tumor microenvironment, using both qualitative and quantitative comparative approaches. The guidelines from the International Society for Extracellular Vesicles (ISEV) were used as a kind of standard for study rigor.

Key Findings: A growing body of research suggests that exosomes work as important intercellular message carriers, meaning they are deeply involved in cancer metastasis. Their nano-sized form, the potential to move across the blood-brain barrier (BBB), and their inherent biocompatibility make them a stronger, more natural alternative in comparison with synthetic nanoparticles. Innovative methods such as microfluidics have cut the isolation time a lot, and pairing exosomes with the CRISPR-Cas system has basically opened new directions for gene therapy. In the end, the review also tackles difficulties in standardization and large-scale production, while stressing that exosome engineering is likely the upcoming step change for precision cancer therapy.

---

Keywords :

Biological characteristics, Cancer, exosome, methods.

---

References :

1. Di Bella MA. Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine. Biology. 2022;11(6):804.
2. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478): eaau6977.
3. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581-593.
4. Li X-X, Yang L-X, Wang C, et al. The Roles of Exosomal Proteins: Classification, Function, and Applications. Int J Mol Sci. 2023;24(4):3061.
5. Jin Y, Xing J, Xu K, Liu D, Zhuo Y. Exosomes in the tumor microenvironment: Promoting cancer progression. Front Immunol. 2022; 13:1025218.
6. Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56.
7. Mukerjee N, Bhattacharya A, Maitra S, et al. Exosome isolation and characterization for advanced diagnostic and therapeutic applications. Materials Today Bio. 2025; 31:101613.
8. Witwer KW, Thery C. Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. J Extracel Vesicles. 2019;8(1):1648167.
9. Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
10. Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018; 2018:8545347.
11. Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011;21(1):77-91.
12. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244-1247.
13. van Niel G, Charrin S, Simoes S, et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell. 2011;21(4):708-721.
14. Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie. 2007;89(2):205-212.
15. Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol. 2003; 19:397-422.
16. Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation – efforts for efficient exosome-based theranostics. 2020;10(8):3684-3707.
17. Villazon J, Dela Cruz N, Shi L. Cancer Cell Line Classification Using Raman pectroscopy of Cancer-Derived Exosomes and Machine Learning. Anal Chem. 2025;97(17):7289-7298.
18. Zhao X, Zhang W, Qiu X, Mei Q, Luo Y, Fu W. Rapid and sensitive exosome detection with CRISPR/Cas12a. Anal Bioanal Chem. 2020;412(3):601-609.
19. Zhang P, He M, Zeng Y. Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating. Lab Chip. 2016;16(16):3033-3042.
20. Contreras-Naranjo JC, Wu HJ, Ugaz VM. Microfluidics for exosome isolation and analysis: Enabling liquid biopsy for personalized medicine. Lab Chip. 2017;17(21):3558-3577.
21. O’Loughlin AJ, Woffindale CA, Wood MJA. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther. 2012;12(4):262-274.
22. El Andaloussi S, Lakhal S, Mäger I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev. 2013;65(3):391-397.
23. Mukerjee N, Bhattacharya A, Maitra S, et al. Materials Today Bio. 2025; 31:101613.
24. Zhang M, Hu S, Liu C, et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023;8(1):124.
25. Tian J, Han Z, Song D, et al. Engineered exosome for drug delivery: recen development and clinical applications. Int J Nanomed. 2023; 18:7923-7940.
26. Saari H, Lázaro-Ibáñez E, Viitala T, et al. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015; 220:727-737.
27. Wang X, Li D, Li G, et al. Enhanced therapeutic potential of hybrid exosomes loaded with paclitaxel for cancer therapy. Int J Mol Sci. 2024;25(7):3645.
28. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat Med. 1998;4(5):594-600.
29. Pitt JM, André F, Amirogena S, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224-1232.
30. Di Bella MA. Biology. 2022;11(6):804.
31. Yin F, Wang WY, Jiang WH. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms. World J Stem Cells. 2019;11(8):548-564.
32. Doeppner TR, Herz J, Gorgens A, et al. Extracellular Vesicles ImprovePost-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med. 2015;4(10):1131-1143.
33. Willis GR, Kourembanas S, Mitsialis SA. Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency. Front Cardiovasc Med. 2017; 4:63.
34. Witwer KW, Thery C. J Extracell Vesicles. 2019;8(1):1648167.
35. Yamashita T, Takahashi Y, Takakura Y. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application. Biol Pharm Bull. 2018;41(6):835-842.
36. Shaimardanova AA, Solovyeva VV, Chulpanova DS, et al. Extracellular vesicles in the diagnosis and treatment of central nervous system diseases. Neural Regen Res. 2020;15(4):586-596.
37. Alshuhri M, Al-Musawi SG, Uinarni H, et al. new horizons in tumor microenvironment biology. Pathol Res Pract. 2024; 253:154996.
38. Li S, Yi M, Dong B, Tan X, Luo S, Wu K. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction. Int J Cancer. 2021;148(11):2640-2651.
39. Pullan JE, Confeld MI, Osborn Jk, et al. Exosomes as drug carriers for cancer therapy. Mol Pharm. 2019;16(5):1789-1798.
40. Zhang X, Yuan X, Shi H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015; 8:83.
41. Wu JY, Li YJ, Hu XB, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci 2017;114(40):10584-10589.
42. Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177-182.
43. Sandfeld-Paulsen N, Aggerholm-Pedersen R, Bæk KR, et al. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer. Mol 2016;10(10):1595-1602.
44. Grimolizzi F, Monaco F, Leoni F, et al. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer. Sci Rep. 2017;7(1):15277.
45. Wang C, Ding Q, Plant P, et al. Droplet digital PCR enabled by microfluidic impact printing for absolute gene quantification. Talanta. 2020; 211:120680.
46. Zhang Y, Zhao J, Dong J, et al. A system and method for isolation and detection of exotic tumor marker miRNA. CN201910064022.7.
47. Villazon J, Dela Cruz N, Shi L. Cancer Cell Line Classification Using Raman Spectroscopy of Cancer-Derived Exosomes and Machine Learning. Anal Chem. 2025;97(17):7289-7298.
48. Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018; 2018:8545347.
49. Di Bella MA. Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine. Biology. 2022;11(6):804.
50. Kalra H, Adda CG, Liem M, et al. Comparative proteomics evaluation of plasma exosome isolation techniques. Proteomics. 2013;13(22):3354-3364.
51. Betsou F, Lehmann S, Ashton G, et al. Standard preanalytical coding for biospecimens: Defining the sample PREanalytical code. Cancer Epidemiol Biomark Prev. 2010;19(4):1004-1011.
52. Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25(1):1234-1257.
53. Horodecka K, Düchler M. CRISPR/Cas9: principle, applications, and delivery through extracellular vesicles. Int J Mol Sci. 2021;22(11):6072.
54. Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer. Carcinogenesis. 2009;30(7):1073-1081.
55. Pitt JM, André F, Amirogena S, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224-1232.
56. Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329-335.
57. Zhang K, Liu D, Zhao J, et al. nuclear exosome Hmgb3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis. Cell Death Dis. 2021;12(6):554.
58. Mukerjee, N., Bhattacharya, A., Maitra, S., Kaur, M., Ganesan, S., Mishra, S., … & Thorat, N. D. (2025). Exosome isolation and characterization for advanced diagnostic and therapeutic applications. Materials Today Bio, 31, 101613.
59. Willms, E., Johansson, H. J., Mäger, I., Lee, Y., Blomberg, K. E. M., Sadik, M., … & Vader, P. (2016). Cells release subpopulations of exosomes with distinct molecular and biological properties. Scientific reports, 6(1), 22519.
60. Park, S. H., Lee, E. K., Yim, J., Lee, M. H., Lee, E., Lee, Y. S., & Seo, W. (2023). Exosomes: nomenclature, isolation, and biological roles in liver diseases. Biomolecules & Therapeutics, 31(3), 253.
61. Fotsitzoudis, C., Koulouridi, A., Messaritakis, I., Konstantinidis, T., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2022). Cancer-associated fibroblasts: The origin, biological characteristics and role in cancer—A glance on colorectal cancer. Cancers, 14(18), 4394.
62. Jin, Y., Xing, J., Xu, K., Liu, D., & Zhuo, Y. (2022). Exosomes in the tumor microenvironment: Promoting cancer progression. Frontiers in immunology, 13, 1025218.